Laxmi Organic Industries Ltd. · NSE:LXCHEM
Laxmi Organic Industries — Q4 FY24 Earnings Presentation
32 slides from Laxmi Organic Industries's earnings presentation, May 23, 2024
Slide 1: Cover letter to stock exchanges
May 23, 2024 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, 1st Floor, New Trading Ring, Bandra (E), Rotunda Building, P. J. Towers, Mumbai – 400 051 Dalal Street, Fort, Trading Symbol: LXCHEM Mumbai – 400 001 Scrip Code:
Slide 2: Geared to Win – Analyst Presentation Q4 & FY24
Geared to Win – Analyst Presentation Investor Presentation – Q4 & FY24 23 May 2024 www.laxmi.com
Slide 3: Disclaimer
Disclaimer This presentation and the accompanying slides (the “Presentation”), have been prepared by Laxmi Organic Industries Limited (the “Company”) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall no
Slide 4: Who we are?
Who we are? Essentials: Lean & Reliable supplier Specialties: World Class Technology serving diverse industries platforms with strong development capabilities serving diverse industries Large, global addressable markets Emphasis on Development, Quality, across Essentials (>USD 12bn) and and ESG, Res
Slide 5: Diversified Business Catering to Varied Industries
Diversified Business Catering to Varied Industries Essentials Specialties End User Industries Pharmaceuticals Agrochemicals Inks & Paints Coatings Pharmaceuticals Agrochemicals Dyes & Pigments Fragrance & Flavour Printings Packaging Adhesives Fragrance & Flavour Paints & Coating Flame Redundant Elec
Slide 6: Leadership Ambitions
Geared to Win Demonstrated 1 Cost and Technology leadership capability of Leadership absorbing and Market leadership – top 3 in scaling best in 2 Essentials (ex-China) and top 5 class in Specialties globally technologies Unlevered Balance Sheet – 3 Partner of choice for customers ready to invest Lar
Slide 7: Geared to Win – Innovation pipeline
Geared to Win – Innovation pipeline Revenue Investment Continue >20% Revenue New Products Contribution from Continue to New Products in invest 2% of Infrastructure Specialties* Strong Pipeline – Specialties 11 products are in revenues for Piloting assets pilot and capex Innovation Innovation and Kil
Slide 8: Geared to Win – Some Recent Success Stories
Geared to Win – Some Recent Success Stories Developed Developed Ethylene Oxide chemistry from laboratory – gram to commercial – on scale for a global innovator Customer Focused Projects – On Spec & On Time Scaled Absorbed and scaled up mercaptan chemistry for an industry leading agrochemicals innova
Slide 9: Geared to Win– Strategically located Manufacturing Sites
Geared to Win– Strategically located Manufacturing Sites India Mahad (2 Sites) Manufacturing Units 3rd party storage tank agreements • Land parcel: 45 acres • Land Occupancy: 90% • Product Mix: o Essentials – 60% o Specialties – 40% Dahej* Europe Dahej* Lote* Mahad, Maharashtra (2 units) • Land parc
Slide 10: Geared to Win– Network and Alliances
Geared to Win– Network and Alliances Ravi Goenka Dr Rajan Venkatesh Harshvardhan Goenka Rajeev Goenka Manish Chokhani Executive Chairman Managing Director & Chief Executive Director – Strategy Non-Executive Director Independent Director Executive Officer & Business Development Bachelor’s degree in C
Slide 11: Geared to Win – Strong Management Team
Geared to Win – Strong Management Team Dr Rajan Venkatesh Harshvardhan Goenka Tanushree Bagrodia S. Daipayan Bora Uday Vaishampayan Managing Director & Chief Executive Director – Strategy Chief Financial Officer Chief Transformation Officer Sr. Vice President Corporate EHS Executive Officer & Busine
Slide 12: Living Our Values to Deliver our Ambitions
Living Our Values to Deliver our Ambitions INTEGRITY INNOVATION To do what is right in the interest of all To create a culture where failure is our stakeholders with an unwavering the first step to success focus CUSTOMER CENTRICITY SUSTAINABILITY To improve the lives of our customers To make a posit
Slide 13: Accreditation & Certification
Accreditation & Certification Recognized for its sustainable practices Accredited facilities Biobased Product Label for Ethyl Acetate Going beyond the regulatory compliances Disclosure of Business Responsibility & Sustainability Report (BRSR) LAXMI ORGANIC INDUSTRIES LIMITED| Q4 & FY24 12
Slide 14: Awards & Accolades
Awards & Accolades State Level Award - DISH Certificate of Appreciation from National Safety Council of India for consecutive 3 years Best Supporter for fire mitigation National Level Unit II: National Level EHS Merit Award 4th Level awards from National Safety Council of India – Announced in Dec. 2
Slide 15: Financial Highlights Q4 & FY24
Financial Highlights Q4 & FY24 www.laxmi.com
Slide 16: From the desk of MD & CEO
From the desk of MD & CEO Commenting on the Q4 & FY24 results, Dr Rajan Venkatesh – MD & CEO says, “Despite the challenging industry operating backdrop, we have delivered strong growth in volumes, profitability and operating cash flow in FY24. Our performance for both Q-o-Q and Y-o-Y basis delivered
Slide 17: Business Update – On Capex
Business Update – On Capex Particulars Lote Dahej • Shifting of supply chains (China +1) Leveraging World class Fluro intermediates technology • Growing end products markets • Growth of Domestic market Rs. 5,500 Mn Rs. 7,100 Mn Investments Achieved revised timelines Relevant approvals received and T
Slide 18: Standalone Financial Highlights – Q4FY24
Standalone Financial Highlights – Q4FY24 (in INR Mn.) Total Income EBITDA* PAT +15% +44% +113% 8,260 1,060 551 7,179 6,984 734 705 392 259 Key Highlights • Volumes for Q4FY24 were up by Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 14% on Q-o-Q and 23% Y-o-Y. • Higher volumes in Ess
Slide 19: Consolidated Financial Highlights – Q4FY24
Consolidated Financial Highlights – Q4FY24 (in INR Mn.) Total Income EBITDA* PAT +9% +52% +82% 8,000 979 443 7,370 6,996 645 272 576 243 Key Highlights • Total Income for Q4FY24 grew by Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 Q4FY23 Q3FY24 Q4FY24 9% on Y-o-Y basis driven by higher volumes in both
Slide 20: Key Financial Highlights – FY24
Key Financial Highlights – FY24 (in INR Mn.) Total Income Standalone EBITDA* Standalone PAT Margins 10.0% 11.1% 5.0% 5.4% +6% +17% +16% Standalone 27,195 28,731 3,190 1,557 Key Highlights 2,723 1,347 • Volumes for FY 24 are up by 20% and this has enabled a robust topline. FY23 FY24 FY23 FY24 FY23 FY
Slide 21: Business Highlights - Q4 & FY24
Business Highlights - Q4 & FY24* (in INR Mn.) Essentials Revenue Specialties Revenue +3% +15% 19,494 8,427 18,856 7,313 +12% +16% 2,198 2,469 4,617 4,948 5,346 1,876 Q4FY23 Q3FY24 Q4FY24 FY23 FY24 Q4FY23 Q3FY24 Q4FY24 FY23 FY24 EBIDTA Contribution (in %) Essential Specialty 31% 33% FY23 FY24 69% 67%
Slide 22: De-risked Business Model continues to Deliver
De-risked Business Model continues to Deliver* Exports Continue to remain Relevant Diversified Exports – FY24 Exports 9% 20% 14% Domestic 29% 35% 30% 32% 20% FY23 26% FY24 55% 5% 80% 71% 65% 70% 11% 19% 8% Europe Africa Middle East FY21 FY22 FY23 FY24 Rest of Asia Pacific America Revenue from Top 10
Slide 23: Standalone Profit & Loss – Q4 & FY24
Standalone Profit & Loss – Q4 & FY24 (in INR Mn.) Profit and Loss (in INR Mn.) Q4 FY24 Q4 FY23 Y-o-Y Q3 FY24 Q-o-Q FY24 FY23 Y-o-Y Total Income 8,260 7,179 15.1% 6,984 18.3% 28,731 27,195 5.6% COGS 5,278 4,753 4,727 18,918 17,791 Gross Profit 2,982 2,426 22.9% 2,257 32.1% 9,813 9,404 4.4% GP Margin
Slide 24: Consolidated Profit & Loss – Q4 & FY24
Consolidated Profit & Loss – Q4 & FY24 (in INR Mn.) Profit and Loss (in INR Mn.) Q4 FY24 Q4 FY23 Y-o-Y Q3 FY24 Q-o-Q FY24 FY23 Y-o-Y Total Income 8,000 7,370 8.5% 6,996 14.3% 28,932 28,087 3.0% COGS 5,040 4,880 4,812 19,248 18,552 Gross Profit 2,960 2,490 18.9% 2,184 35.5% 9,685 9,535 1.6% GP Margin
Slide 25: Consolidated Balance Sheet
Consolidated Balance Sheet (in INR Mn.) Assets (in INR Mn.) Mar-24 Mar-23 Equity and Liabilities (in INR Mn.) Mar-24 Mar-23 ASSETS EQUITY AND LIABILITIES Non-current assets Equity Share Capital 552 530 Property, Plant and Equipment 8,708 7,057 Other Equity 17,425 13,587 Capital work-in-progress 4,44
Slide 26: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (in INR Mn.) Particulars (in INR Mn.) Mar-24 Mar-23 Profit before Tax 1,708 1,729 Adjustment for Non-Operating Items 1,192 896 Operating Profit before Working Capital Changes 2,900 2,625 Changes in Working Capital 3,086 (133) Cash Generated from Operations 5,986 2,49
Slide 27: Key Ratios – On Consolidated Basis
Key Ratios – On Consolidated Basis CFO / EBITDA (%) Return on Capital Deployed* (%) Debt : Equity (x) 211% 18% 0.3 15% 97% 0.1 FY23 FY24 FY23 FY24 FY23 FY24 *Excl. CWIP & QIP balances LAXMI ORGANIC INDUSTRIES LIMITED| Q4 & FY24 26
Slide 28: Rationale for Proposed Merger of YFCPL
Rationale for Proposed Merger of YFCPL Laxmi Organic Industries Limited has proposed the merger of its 100% subsidiary Yellowstone Fine Chemicals Private Limited (YFCPL). YFCPL has been engaged in the business of manufacturing of fluoro specialty products and other chemical products. The amalgamatio
Slide 29: CSR Highlights of FY24
CSR Highlights of FY24 www.laxmi.com
Slide 30: CSR Focus Areas & Outcomes
CSR Focus Areas & Outcomes 1 SUSTAINABILITY 2 HEALTH Outcome Outcome ▪ Shift from conventional source ▪ Solving for short term and mid Mobile Health Units ▪ 100 Solar Lamps , 2 Villages , of electricity infrastructure to term health needs of masses ▪ 2 MHU Units , ▪ 6500 + Beneficiaries renewable in
Slide 31: CSR in Action
CSR in Action GLIMPSES OF SOLAR LAMP VIEW OF MOBILE HEALTH UNIT OPERATIONS 30
Slide 32: Thank You
Thank You Company: Laxmi Organic Industries Limited Investor Relations: Strategic Growth Advisors Pvt. Ltd. www.laxmi.com www.sgapl.net CIN: L24200MH1989PLC051736 CIN: U74140MH2010PTC204285 Mr. Nishant Dudhoria / Ms. Prachi Chhugani Mr. Aniket Hirpara Email: nishant.dudhoria@sgapl.net / prachi.c@sga
Laxmi Organic Industries — Q4 FY24 Earnings Presentation on 6ix